Form 4: Maravai LifeSciences Holdings Director Carl Hull Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Carl Hull, a director and Executive Chairman of Maravai LifeSciences Holdings, reported changes in beneficial ownership of Class A Common Stock due to tax withholding obligations and holdings through Glossatori, LLC.
Summary
- On March 15, 2024, Carl Hull, Executive Chairman and a director of Maravai LifeSciences Holdings, reported a transaction involving Class A Common Stock.
- 17,560 shares were disposed of to satisfy tax withholding obligations related to the vesting of restricted stock units at a price of $7.7 per share.
- Following the transaction, Hull directly owns 267,072 shares of Class A Common Stock.
- Hull also indirectly owns 35,000 shares through Glossatori, LLC.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing regarding changes in beneficial ownership, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it is primarily related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of transaction involving Class A Common Stock. |
| 03/18/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.